Atlas Trials

Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites

Clinical trial NCT02172755 · COMPLETED

Trial details

NCT number
NCT02172755
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2002-06-01
Primary completion
2002-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.